Avalon Trust’s Medpace MEDP Stock Holding History

Avalon Trust’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$11.1K	Hold	21	–	–	﹤0.01%	398
2026 Q1	$10.1K	Buy	+21	New	+$10.8K	﹤0.01%	400

Other funds holding MEDP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Avalon Trust's MEDP Position: Q2 2026 in Review

Avalon Trust held its Medpace (MEDP) position steady in Q2 2026 at 21 shares worth $11.1K. The position accounts for ﹤0.01% of the portfolio, ranked #398.

Avalon Trust first reported a position in MEDP in Q1 2026 and has held it in 2 quarters since. 697 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

Avalon Trust held 21 shares of Medpace worth $11.1K as of Q2 2026.
Avalon Trust left its Medpace share count unchanged in Q2 2026.
Medpace made up ﹤0.01% of Avalon Trust's portfolio in Q2 2026, its #398 holding.
Avalon Trust first reported a position in Medpace in Q1 2026 and has held it in 2 quarters since.
697 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Avalon Trust's 13F filing for Q2 2026, filed 6 Aug 2026.